Recent studies have suggested that large amounts of free zinc may be coreleased during excitatory synaptic transmission at glutamatergic synapses, and may act postsynaptically to decrease actions mediated by Kmethyl-o-aspartate (NMDA) receptors, while often increasing neuroexcitation mediated by quisqualate receptors.
The present study examined the ability of zinc to alter excitatory amino acid (EAA) neurotoxicity.
Murine cortical cell cultures were exposed to EAAs for 5 min in defined solutions, and neuronal cell injury was examined the following day both morphologically and by lactate dehydrogenase assay. Inclusion of 30400 PM zinc in the exposure solution produced a zinc concentration-dependent, noncompetitive attenuation of NMDA-induced neuronal injury, with an ED,, of about 80 PM. In contrast, zinc produced the same concentration-dependent potentiation of quisqualate neurotoxicity; and with 500 PM zinc, a small potentiation of kainate neurotoxicity was suggested. The effect of zinc on the neurotoxicity of the broad-spectrum agonist glutamate was consistent with these effects on specific agonists, as well as with a previous study showing that glutamate neurotoxicity normally depends predominantly on NMDA-receptor activation.
Zinc produced a concentrationdependent reduction in glutamate-induced neuronal injury in a fashion similar to that seen with NMDA, but less effectively. In addition, despite this overall protective effect, zinc paradoxically increased the glutamate-induced destruction of nicotinamide adenine dinucleotide phosphate diaphorase (NADPH-d)-containing neurons, a subpopulation that was shown in the preceding paper Several investigators have now postulated that the release of glutamate (and related compounds) at central excitatory synapses may commonly be accompanied by the corelease of substantial amounts of free zinc (Zn). Mammalian brain, especially Received July 20, 1987; revised Oct. 19, 1987; accepted Oct. 20, 1987 . We thank M. P. Goldberg and S. Peters for helpful discussions, and V. Viseskul for expert assistance with cell cultures. This research was supported by NIH Grants NS21628 and NS1215 1, and by a Hartford Fellowship (to D.W.C.) from the John A. Hartford Foundation. the preceding paper .
Methods
neocortex, pineal, and hippocampus (Wong and Fritze, 1969; Donaldson et al., 1973; Frederickson et al., 1982) , contains considerable amounts of Zn. While Zn is likely a cofactor in myriad metabolic processes (Vallee, 1959) , histochemical methods have revealed foci of chelatable Zn (Danscher et al., 198.5) , specifically in forebrain neuropil (Haug, 1973) , and ultrastructural studies have further suggested that much of this Zn is located within certain synaptic vesicles in excitatory synaptic boutons (Ibata and Otsuka, 1969; Perez-Clause11 and Danscher, 1985) . Release of endogenous Zn to the extracellular space appears to occur spontaneously (Charton et al., 1985; Perez-Clausell and Danscher, 1986) , and has been shown to be increased in a calcium-dependent fashion by either high-potassium or electrical stimulation (Assaf and Chung, 1984; Howell et al., 1984; Aniksztejn et al., 1987) .
The function of such synaptically released Zn is at present unknown, although some participation in excitatory neurotransmission seems probable. Recently, we reported that Zn could selectively attenuate N-methyl-D-aspartate (NMDA) receptormediated excitation of cortical neurons, while producing some potentiation ofquisqualate receptor-mediated excitation (Peters et al., 1987) . On the basis of this finding, we proposed that the corelease of Zn with glutamate at central excitatory synapses may normally serve to modulate the distribuion of receptor subtypes activated by glutamate, decreasing the activation of NMDA receptors while increasing the activation of quisqualate receptors.
If indeed Zn is coreleased with synaptically released glutamate, it might not only modify the postsynaptic effects of glutamate during the brief exposures associated with normal synaptic transmission, but it could also importantly modify the neurotoxicity of extracellular glutamate during the prolonged exposures thought to occur in certain disease states (Rothman and Olney, 1987) . Glutamate neurotoxicity, as modified by Zn, could be highly relevant to the pathophysiology of neuronal loss in these disease states-in some brain regions, perhaps more directly than glutamate neurotoxicity alone.
We have previously reported that Zn could selectively attenuate NMDA-induced cortical neuronal damage (Peters et al., 1987) . The purpose of the present study was to extend that observation, characterizing in greater detail the effect of Zn on EAA neurotoxicity. On the basis of the preceding study of the selective vulnerability of NADPH-d-containing [NADPH-d( +)] neurons , we utilized the fate ofthis special subpopulation as an assay for distinguishing NMDA receptormediated neurotoxicity from non-NMDA receptor-mediated neurotoxicity.
The Journal of Neuroscience, June 1988, 8(6) Figure 1 . Zn blocks NMDA neurotoxicity in a concentration-dependent manner. Closed circles show LDH efflux (mean and SEM, n = 4) to the bathing medium in a set of matched sister cultures exposed to 500 PM NMDA for 5 min, with the indicated concentration ofZn added to the exposure solution. Open circles show the same for other sister cultures exposed for 5 min to Zn alone (Zn only). LDH values were scaled to the mean value observed in a set of matched control cultures exposed to 500 FM NMDA alone for 5 min (=lOO). At 300 FM, Zn completely blocked both the morphological and chemical evidence of neuronal injury. At 1 mM, Zn showed some intrinsic neurotoxicity.
Zn chloride (ACS reagent grade) was obtained from Sigma. Other inorganic salts were Baker reagent grade with negligible listed Zn contamination. Tris was obtained from Sigma (reagent grade).
The only major source of Zn known to be present in the culture media was that contributed by the sera (Hyclone Defined), producing a net Zn concentration of ~6 PM in the plating medium, and ~2 PM in the maintenance medium (estimate based on the supplier's assay of sera Zn concentrations). Water used to prepare the media and the exposure solutions (see below) was obtained from a Millipore Mini-Q purification system (R > 15 MB cm).
Results
As previously described, the widespread cortical neuronal cell loss produced by exposure to 500 FM NMDA for 5 min could be essentially eliminated by the addition of 300 PM Zn to the exposure solution; neurons remained morphologically intact and excluded trypan blue dye (Peters et al., 1987) . This protective effect of Zn was concentration-dependent, and could be quantitated by measuring the LDH released to the bathing medium by injured neurons. Thirty micromolar Zn produced little neuronal protection, and 100 FM Zn produced partial protection ( Fig. 1) . Whereas Zn concentrations of 300 WM or less did not exhibit intrinsic neurotoxicity (with this 5 min exposure), 1 mM Zn alone was somewhat neurotoxic (Yokoyama et al., 1987) ; thus the resulting Zn concentration-NMDA neurotoxicity relationship was U-shaped, with minimum net neuronal damage observed at 300 PM Zn (Fig. 1) .
The concentration-toxicity relationship characterizing a 5 min exposure to NMDA was presented in the preceding paper . The selective NMDA antagonist, 2-amino-5-phosphonovalerate (APV) has been previously shown to competitively antagonize NMDA-induced neuroexcitation (Davies et al., 198 1; Olverman et al., 1984) . If APV was added to the exposure solution, the NMDA concentration-toxicity relationship was shifted in grossly parallel fashion to the right, with little or no change in maximal neurotoxicity (Fig. 2) , consistent with competitive inhibition of neurotoxicity. However, whereas
Zn block of NMDA neurotoxicity is noncompetitive. Concentration-toxicity relationship (mean and SEM LDH efflux, n = 4) for a 5 min exposure to NMDA in the presence of 100 PM APV (circles) is compared to that in the presence of 200 PM Zn (squares). The comparison was done on a large set of matched sister cultures; LDH values have been scaled to the mean value of other sister cultures exposed to 3 mM NMDA alone. For comparison, the dotted line shows a similarly scaled concentration-toxicity relation obtained for NMDA alone in another experiment (Koh and Choi, 1988, Fig. 5A ).
the addition of 200 KM Zn produced less neuronal protection than 100 I.LM APV at low (300 FM or less) NMDA concentrations, the Zn block, unlike the APV block, was not overcome at higher NMDA concentrations (Fig. 2) . We previously reported that Zn not only reduced NMDA receptor-mediated neuroexicitation and neurotoxicity, but also reliably potentiated quisqualate neuroexcitation (Peters et al., 1987) . Some suggestion of potentiation of quisqualate and kainate neurotoxicity was seen (Peters et al., 1987) but those experiments were directed toward establishing the selectivity of NMDA antagonism, and employed high agonist concentrations. Under exposure conditions designed to produce only minimal amounts of quisqualate-induced neuronal injury ) the addition of 500 PM Zn dramatically increased quisqualate-induced neuronal injury, as judged both morphologically ( Fig. 3) and by lactate dehydrogenase (LDH) efflux (Fig.  4) . A similar, but lesser, potentiation of low-grade kainate neurotoxicity was suggested (Figs. 3, 4) . Control experiments in sister cultures showed that 5 min exposure to 500 PM Zn alone was associated with little neuronal injury (Fig. 4) .
The ability of Zn to potentiate quisqualate neurotoxicity was concentration-dependent over approximately the same concentration range (30 MM to 1 mM) as the ability of Zn to attenuate NMDA neurotoxicity (Fig. 5) . At concentrations approaching 1 mM, however, the emergence of intrinsic Zn neurotoxicity likely contributed to net neuronal injury. Although glutamate produces its neuroexcitatory effects on cortical neurons by activating both NMDA and non-NMDA receptors (Watkins and Evans, 198 l) , previous experiments have shown that the neurotoxicity of brief glutamate exposure on cortical neurons depends predominantly on activation of the former . The prediction that Zn might therefore attenuate the net neuronal loss produced by glutamate was tested directly. Cortical cultures exposed to 500 PM glutamate for 5 min showed, as expected (Choi et al., 1987a) , progressive neuronal disintegration over the following day (Fig. 6A) . If 300 control (no agonist). Agonist concentrations were NMDA, 500 /IM; quisqualate (QUls), 30 FM; and kainate (KAZN), 1 mM. LDH values were scaled to that produced by 500 NM NMDA (= 100). A low concentration ofquisqualate (30 KM) was intentionally chosen to make any potentiating effect more conspicuous; kainate was previously established to be a weak neurotoxin with 5 min exposure . Zn produced the expected attenuation of NMDA-induced neurotoxicity, but potentiated the neurotoxicity of quisqualate, and, to a lesser extent, kainate; Zn alone produced little neuronal injury. * Significant difference compared with the agonist-only condition: p < 0.01; 2-tailed t test.
PM Zn was included in the exposure solution, this glutamateinduced neuronal loss was markedly reduced (Fig. 6B) . Like the protective effect of Zn on NMDA neurotoxicity, the protective effect of Zn on glutamate showed a U-shaped Zn concentration dependence, with maximal protective effect at 300 FM (Fig. 7) .
Even at 300 PM Zn, however, there were still substantial amounts of residual glutamate-induced neuronal injury, in distinction to the near-zero injury seen after the addition of 300 PM Zn to NMDA (Fig. I) , or to the addition of 1 mM D-APV to glutamate . We hypothesized that some of this residual injury reflected the Zn-augmented, non-NMDA receptor-mediated toxicity of glutamate.
To test this hypothesis, we studied the effect of Zn on the fate of the cortical neuronal subpopulation containing high concentrations of NADPH-d( +) neurons, a marker population shown in the preceding paper to be selectively resistant to NMDAreceptor agonists, and selectively vulnerable to non-NMDAreceptor agonists . Cultures exposed to glutamate showed similar degrees of widespread neuronal loss and NADPH-d( +) neuronal loss . Despite the fact that addition of 300 WM Zn to the glutamate exposure solution markedly attenuated the overall number of neurons destroyed by glutamate, it significantly increased loss of the NADPH-d( +) subpopulation, virtually eliminating these cells from the cultures (Fig. 8) 
(5 of 5 experiments).
This differential effect of Zn on the vulnerability of the overall cortical neuronal population and on the NADPH-d( +) subpopulation was not mimicked by several other selective NMDA antagonists: 1.5 mM APV and 20 PM dextrorphan (Church et al., 1985; Choi et al., 1987b) attenuated glutamate neurotoxicity to a greater degree than 300 PM Zn, but did not potentiate glutamate-induced NADPH-d( +) neuronal cell loss (Fig. 9) . Figure 1 , LDH efflux is scaled to the mean value observed in sister cultures exposed to 500 PM NMDA for 5 min (= 100).
Magnesium (Mg) (10 mM) produced little effect on either overall glutamate neurotoxicity or glutamate-induced NADPH-d( +) neuronal cell loss (Fig. 9 ).
Discussion
The present study quantitatively describes a novel set of interactions between Zn and the neurotoxicity of EAAs on cortical neurons. At bath concentrations between 30 and 500 PM, Zn selectively attenuated the neurotoxicity of NMDA, while potentiating the neurotoxicity of quisqualate and perhaps also of kainate. These Zn effects parallel some recently observed effects on EAA neuroexcitation, both in cortical cultures (Peters et al., 1987) and in hippocampal cultures (Westbrook and Mayer, 1987) . The most striking effect of Zn observed here was attenuation of NMDA neurotoxicity, which occurred with an ED,, of approximately 80 PM; 300 PM Zn virtually eliminated NMDAinduced neuronal cell injury under the present conditions. This blockage occurred in a noncompetitive fashion: unlike the block produced by APV, the Zn block was not overcome by concentrations of NMDA as high as 3 mM.
In contrast, the same concentrations of Zn potentiated the neurotoxicity of low concentrations of quisqualate. This potentiating effect was most clearly apparent at Zn concentrations of 100-500 PM, which showed little or no intrinsic toxicity with the 5 min exposures used; 1 mM Zn further increased net neuronal injury, but did itself produce injury. The potentiating effect of Zn was less striking with kainate than with quisqualate: 500 PM Zn increased quisqualate neurotoxicity more than IO-fold, but increased kainate neurotoxicity only 2-3-fold.
As previous observations suggested that glutamate neurotoxicity was predominantly mediated by NMDA receptors Zn also considerably reduced net glutamate neurotoxicity. Unlike NMDA neurotoxicity, however, glutamate neurotoxicity was not eliminated by even optimal (300 PM) Zn concentrations: over a third remained. This residual is substantially more than the near-zero residual glutamate neurotoxicity Figure 8 . Zn modulates the nature of glutamate neurotoxicity. As can be seen in the left-hand bars (mean +-SEM LDH efflux. n = 3 or 4). the addition of 300 PI,I Zn (Gbr + Zn) markedly attenuated the overaii neuronal injury produced by 500 PM glutamate (Glu), and the same exposure to Zn alone (Zn) had little toxicity. LDH efflux was scaled to that produced by 500 PM glutamate exposure alone (= 100). Figure 7 . Zn attenuates glutamate neurotoxicity in a concentrationdependent manner. Cultures were exposed to 500 PM glutamate for 5 min in the presence of the indicated concentrations of Zn (Glu + Zn); other matched sister cultures were exposed to the Zn alone (Zn only). LDH in the bathing medium (mean -C SEM, n = 3 or 4) was measured the following day, and scaled to the mean value of other matched cultures exposed to 500 PM glutamate atone. At 300 PM, Zn substantially antagonizes glutamate neurotoxicity, but at higher concentration (1 mM), Zn exhibits intrinsic toxicity.
left by selective NMDA antagonism with 1 mM D-APV . It is tempting to postulate that this increased residual reflects potentiation of the normally minimal quisqualate receptor-mediated component of glutamate neurotoxicity.
Supporting this postulate, Zn paradoxically increased the destruction of the NADPH-d(+) neuronal subpopulation by glutamate, even while simultaneously reducing overall cortical neuronal injury. Since NADPH-d( +) neurons are selectively resistant to NMDA receptor-mediated toxicity, but selectively vulnerable to non-NMDA receptor-mediated toxicity , this selective destruction is consistent with an augmentation of the neurotoxic action of glutamate at non-NMDA receptors. In comparison, the simple NMDA antagonists APV, dextrorphan, and Mg did not increase glutamate-mediated NADPH-d(+) neuronal loss.
A total of 10 mM Mg also failed to produce much reduction in overall glutamate neurotoxicity, an observation previously reported (Choi et al., 1987a) and possibly explained, in part, by the relief of the Mg block of the NMDA channel by membrane depolarization (e.g., caused by glutamate action on non-NMDA receptors, or by potassium released by other injured neurons) (Mayer et al., 1984; Nowak et al., 1984) . Full definition of the as yet unknown nature of the interaction between Zn and EAA receptor complexes will likely be required in order to understand why Zn is better than Mg at attenuating glutamate neurotoxicity. The simple postulate that Zn is better able to block the NMDA channel, perhaps especially at depolarized membrane potentials, cannot alone account for the ability of Zn to potentiate both the neuroexcitatory and neurotoxic effects of quisqualate.
The concentrations of Zn required to alter EAA neurotoxicity in the present experiments may well be attained during high levels of synaptic activity, or in pathological conditions associated with neuronal depolarization. Assaf and Chung (1984) estimated that the Zn rapidly released by hippocampal slices exposed to 23 mM K could produce a 300 PM concentration distributed uniformly throughout extracellular space; any lo- However, as summarized in the right-hand bars (mean ? SEM, n = 3 or 4), in the same cultures the addition of Zn to glutamate (but not Zn alone) actuallv increased loss of the NADPHd(+) neuronal subpopulation. NADPH-d(+) neuronal cell counts werenormalized to the number present in wash controls (=0% loss). *Significant difference (p < 0.005) compared with glutamate alone (2-tailed t test with Bonferroni correction to account for 2 comparisons).
calization to synaptic zones would act to increase this figure. Zn could act to fundamentally alter the neurotoxicity of endogenously released glutamate, shifting neurotoxic activation away from NMDA receptors toward quisqualate receptors. This shift would produce a generally neuron-protective effect under most -* 125 Figure 9 . The non-NMDA-potentiating effect of Zn on glutamate neurotoxicity is not produced by other NMDA antagonists. The bars on the left depict mean + SEM LDH efflux produced by 5 min exposure to 500 PM glutamate, either alone (CTRL), or in the presence of 1.5 mM DL-APV (,4W), 20 &M dextrorphan (DX), 300 FM Zn (Zn), or 10 mM Mg (Mg). The bars on the right depict the mean + SEM loss of NADPH-d (+) cells in the same cultures, normalized as above to the number of cells present in sham wash controls (=O% loss). Although both APV and dextrorphan mimicked the ability of Zn to attenuate the general neuronal cell loss produced by glutamate, only Zn simultaneously increased the loss of the NADPH-d(+) neuronal subpopulation in the same cultures (left-hand bars; mean + SEM, n = 3 or 4). APV and dextrorphan both slightly attenuated the damage to NADPH-d(+) cells, but to a degree less than expected from their marked overall protective effect. Magnesium had little or no effect on either the general population or the NADPH-d(+) subpopulation. *Significant differences @ < 0.05) compared with glutamate alone (2-tailed t test with Bonferroni correction for 4 comparisons).
conditions.
It might be interesting to try to correlate the availability of synaptic Zn with neuronal vulnerability to injury in various disease states thought to involve NMDA receptormediated neurotoxicity.
However, the present study also indicates that Zn is potentially a "two-edged sword," capable of selectively increasing EAA-induced injury to certain neurons (e.g., NADPH-d( +) neurons) highly vulnerable to non-NMDA receptor-mediated neurotoxicity.
Furthermore, under conditions of extremely intense Zn release, it is possible that some direct Zn-induced neuronal injury (Yokoyama et al., 1987) might occur.
Selective destruction of NADPH-d(+) neurons is used here simply as a putative experimental index of non-NMDA receptor-mediated neurotoxicity, but it could have intrinsic direct relevance to certain disease states. As discussed in the preceding paper , NADPH-d colocalizes in mammalian forebrain with somatostatin (Vincent et al., 1983; Kowall and Ferrante, 1985) . It is therefore intriguing that a selective loss of somatostatin-containing neurons has been reported to occur in the hippocampal dentate hilus in rat models of both epilepsy (Sloviter, 1987) and cerebral ischemia (Johansen et al., 1987) . The hippocampal dentate hilus is known to have the highest Zn content in the hippocampus (Frederickson et al., 1983) , contained, in large part, in afferent mossy fiber terminals that lose Timm's strain after electrical stimulation (Sloviter, 1985) , and which are likely glutamatergic (Crawford and Connor, 1973) . The neurotoxicity of glutamate and related endogenous EAAs has been postulated to be responsible for much of the neuronal injury produced by epilepsy and hypoxia/ischemia (Rothman and Olney, 1987) , but neither glutamate itself nor aspartate or quinolinate preferentially injures NADPH-d(+) cells . We speculate that a neurotoxic combination ofZn with glutamate might help account for the observed selective depletion of somatostatin-containing neurons in these conditions. Somatostatin-containing neurons may also be injured preferentially in the cortex and hippocampus of Alzheimer's disease patients (Davies et al., 1980; Rossor et al., 1980; Morrison et al., 1985; Roberts et al., 1985; Chan-Palay, 1987) , and in the cortex of patients with Parkinson's disease associated with Alzheimer-type pathology (Beal et al., 1986) . Could this early injury of somatostatin-containing neurons similarly be a clue as to the involvement ofglutamate neurotoxicity (Maragos et al., 1987 )-altered by Zn-in the pathogenesis of Alzheimer's disease?
